SAB Biotherapeutics, Inc.

NASDAQ:SABS

1.72 (USD) • At close July 3, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q4
Omzet 00.11500.2630.9450.3051.2670.08602.1613.596.35111.80360.8760000
Kosten van de omzet 00.7860.9671.0221.9850.9440.9850.8920.9230.9240.910060.2840000
Brutowinst 0-0.6710-0.759-1.04-0.6390.282-0.80701.2372.686.35111.8030.592-0.336-0.25700
Brutowinstmarge 0-5.850-2.884-1.101-2.0960.222-9.43400.5730.747110.010000
Onderzoek- en ontwikkelingskosten 7.6577.637.8316.88.1244.2974.023.6624.5367.1387.3538.58413.32425.71815.0718.68312.7820
Algemene en administratieve kosten 3.1152.6713.4793.6434.18914.8812.5712.93.4472.8834.0444.3095.18617.0863.6012.3993.3320
Verkoop- en marketingkosten 02.9630-1-1.9630000000000000
Verkoop-, algemene en administratieve kosten 3.1151.7083.4793.6434.18914.8812.5712.93.4472.8444.0444.3095.18617.0863.6012.3993.3320.009
Overige kosten 0-0.1150-0.263-0.945-0.305-1.267-0.086-0.581-2.161-3.59-6.351-11.803-61.58-14.681-18.21-16.9280
Bedrijfskosten 10.7729.33811.3099.44310.3518.8745.3235.677.4027.867.8076.5436.70712.6890.3362.873-0.8140.009
Bedrijfsresultaat -10.772-10.009-11.309-10.202-11.391-18.874-5.323-6.477-7.402-7.86-7.807-6.543-6.707-12.689-0.336-2.8730.814-0.009
Bedrijfsresultaat ratio 0-87.2620-38.77-12.059-61.879-4.2-75.7340-3.637-2.175-1.03-0.568-0.2080000
Totaal overige inkomsten en kosten netto 5.575-1.3860.962.8666.365-3.9830.221-0.4040.0480.0110.7311.6757.785-4.8960.005-0.0690.5960
Inkomen voor belasting -5.197-11.395-10.349-7.335-5.026-22.857-5.102-6.881-7.354-7.849-7.076-4.8681.078-17.585-0.331-2.9421.41-0.009
Inkomen voor belasting ratio 0-99.3450-27.877-5.321-74.938-4.026-80.4610-3.632-1.971-0.7670.091-0.2890000
Belastingkosten 0000-13.37500.1670.07500.026-0.731-0.0920.0920.294-0.0050.0770.0750
Nettowinst -5.197-11.395-10.349-7.335-5.026-22.857-5.102-6.881-7.354-7.875-7.076-4.7760.986-17.585-4.061-2.9421.41-0.009
Nettowinstmarge 0-99.3450-27.877-5.321-74.938-4.026-80.4610-3.644-1.971-0.7520.084-0.2890000
WPA (Winst Per Aandeel) -0.562.45-1.12-0.79-0.54-3.86-0.97-1.36-1.46-1.56-1.6-1.110.23-4.11-0.075-0.680.32-0.006
Verwaterde WPA -0.562.45-1.12-0.79-0.54-3.86-0.97-1.36-1.46-1.56-1.6-1.110.22-4.11-0.075-0.680.32-0.006
EBITDA -4.349-10.538-9.305-6.187-2.965-21.834-4.047-5.913-6.338-6.838-6.096-4.0161.828-16.146-3.568-2.5671.762-0.009
EBITDA ratio 0-91.8770-23.513-3.139-71.586-3.193-69.1470-3.164-1.698-0.6320.155-0.2650000